Phase II randomized study of vandetanib plus gemcitabine or gemcitabine plus placebo as first-line treatment of advanced non-small-cell lung cancer in elderly patients.
Gridelli C, Novello S, Zilembo N, Luciani A, Favaretto AG, De Marinis F, Genestreti G, Crinò L, Grossi F, Caffo O, Ferraù F, Cruciani G, Brandes AA, Galetta D, Barni S, Fasola G, Cerea G, Ferrari S, Iannacone C, Ciardiello F.
Gridelli C, et al. Among authors: fasola g.
J Thorac Oncol. 2014 May;9(5):733-7. doi: 10.1097/JTO.0000000000000120.
J Thorac Oncol. 2014.
PMID: 24722160
Free article.
Clinical Trial.